167 related articles for article (PubMed ID: 8928704)
1. Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietin.
Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
Am J Med; 1996 Aug; 101(2A):22S-27S. PubMed ID: 8928704
[TBL] [Abstract][Full Text] [Related]
2. Epoetin alfa as an adjunct to autologous blood donation in patients with a low hematocrit scheduled for elective orthopedic surgery.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):15-6; discussion 17. PubMed ID: 8723575
[TBL] [Abstract][Full Text] [Related]
3. The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trial.
Price TH; Goodnough LT; Vogler WR; Sacher RA; Hellman RM; Johnston MF; Bolgiano DC; Abels RI
Transfusion; 1996 Jan; 36(1):29-36. PubMed ID: 8607150
[TBL] [Abstract][Full Text] [Related]
4. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa plus autologous blood donation in patients with a low hematocrit scheduled to undergo orthopedic surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):22-4; discussion 25-6. PubMed ID: 8723577
[TBL] [Abstract][Full Text] [Related]
6. Enhanced efficacy of autologous blood donation with epoetin alfa.
Nydegger U
Semin Hematol; 1996 Apr; 33(2 Suppl 2):39-40; discussion 41-2. PubMed ID: 8723581
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant human erythropoietin in the perioperative period of orthopedic surgery.
Faris P
Am J Med; 1996 Aug; 101(2A):28S-32S. PubMed ID: 8928705
[TBL] [Abstract][Full Text] [Related]
8. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients.
Baudoux E
Semin Hematol; 1996 Apr; 33(2 Suppl 2):31-2; discussion 33. PubMed ID: 8723579
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Mercuriali F
Semin Hematol; 1996 Apr; 33(2 Suppl 2):18-20; discussion 21. PubMed ID: 8723576
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients.
D'Ambra MN; Gray RJ; Hillman R; Jones JW; Kim HC; Rawitscher R; Schnaper H; Szymanski I; Vlahakes GJ; Kaplan D; Lynch KE; Guilfoyle M; Abels RI
Ann Thorac Surg; 1997 Dec; 64(6):1686-93. PubMed ID: 9436556
[TBL] [Abstract][Full Text] [Related]
11. Epoetin alfa as an adjuvant to autologous blood donation.
Beris P
Semin Hematol; 1996 Apr; 33(2 Suppl 2):27-9; discussion 30. PubMed ID: 8723578
[TBL] [Abstract][Full Text] [Related]
12. Perisurgical use of epoetin alfa in orthopedic surgery patients.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):55-8; discussion 59. PubMed ID: 8723584
[TBL] [Abstract][Full Text] [Related]
13. Potential of epoetin alfa in patients in autologous blood donation programs for orthopedic surgery.
McClelland B
Semin Hematol; 1996 Apr; 33(2 Suppl 2):2-3; discussion 4. PubMed ID: 8723572
[TBL] [Abstract][Full Text] [Related]
14. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
15. Baseline hemoglobin as a predictor of risk of transfusion and response to Epoetin alfa in orthopedic surgery patients.
de Andrade JR; Jove M; Landon G; Frei D; Guilfoyle M; Young DC
Am J Orthop (Belle Mead NJ); 1996 Aug; 25(8):533-42. PubMed ID: 8871751
[TBL] [Abstract][Full Text] [Related]
16. Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.
Markham A; Bryson HM
Drugs; 1995 Feb; 49(2):232-54. PubMed ID: 7729331
[TBL] [Abstract][Full Text] [Related]
17. Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgery.
Cazenave JP; Irrmann C; Waller C; Sondag D; Baudoux E; Genetet B; Laxenaire MC; Dupont E; Sundal E; Obrist R; Stocker H
Eur J Anaesthesiol; 1997 Jul; 14(4):432-42. PubMed ID: 9253573
[TBL] [Abstract][Full Text] [Related]
18. Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Sinigaglia L; Gualtieri G
Vox Sang; 1997; 72(2):93-100. PubMed ID: 9088076
[TBL] [Abstract][Full Text] [Related]
19. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials.
Goldberg MA
Semin Hematol; 1997 Jul; 34(3 Suppl 2):41-7. PubMed ID: 9253783
[TBL] [Abstract][Full Text] [Related]
20. Epoetin alfa for the treatment of the anemia of multiple myeloma. A prospective, randomized, placebo-controlled, double-blind trial.
Garton JP; Gertz MA; Witzig TE; Greipp PR; Lust JA; Schroeder G; Kyle RA
Arch Intern Med; 1995 Oct; 155(19):2069-74. PubMed ID: 7575066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
